Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient

Breast Cancer Research and Treatment
Julie JohnsonFares Al-Ejeh

Abstract

We aimed to generate and characterize a novel cell line from a breast cancer bone metastasis to better study the progression of the disease. The cell line, P7731, was derived from a metastatic bone lesion of a breast cancer patient and assessed for marker expression. P7731 was analyzed for DNA copy number variation, somatic mutations, and gene expression and was compared with the primary tumor. P7731 cells are negative for estrogen receptor alpha (ERα), progesterone receptor (PR), and HER2 (triple-negative); strongly express vimentin (100% of cells positive) and also express cytokeratins 8/18 and 19 but at lower frequencies. Flow cytometry indicates P7731 cells are predominantly CD44+/CD49f+/EpCAM-, consistent with a primitive, mesenchymal-like phenotype. The cell line is tumorigenic in immunocompromised mice. Exome sequencing identified a total of 45 and 76 somatic mutations in the primary tumor and cell line, respectively, of which 32 were identified in both samples and included mutations in known driver genes PIK3CA, TP53, and ARID1A. P7731 retains the DNA copy number alterations present in the matching primary tumor. Homozygous deletions detected in the cell line and in the primary tumor were found in regions containing thr...Continue Reading

References

Aug 4, 1999·Clinical & Experimental Metastasis·E W ThompsonR Clarke
Jan 4, 2001·Journal of Clinical Laboratory Analysis·N I NogueraA C Milani
Aug 3, 2002·Nature Reviews. Cancer·Gregory R Mundy
Nov 9, 2002·BMJ : British Medical Journal·Julie R Gralow
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Nov 6, 2003·Clinical Orthopaedics and Related Research·Manali BendreLarry J Suva
Nov 13, 2004·International Journal of Cancer. Journal International Du Cancer·Jacek GronwaldJan Lubiński
Jan 22, 2005·Clinical Orthopaedics and Related Research·Yin-Gang ZhangJun Li
Feb 1, 2005·Clinical & Experimental Metastasis·Erik W ThompsonRobert Clarke
Feb 3, 2005·Nature Reviews. Drug Discovery·Alexander Kamb
Jul 19, 2005·Cancer Research·Charlotte KuperwasserMichael Rosenblatt
Aug 26, 2006·Journal of Cancer Research and Clinical Oncology·Xiaodong SunJin-Tang Dong
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Feb 21, 2007·Cellular and Molecular Life Sciences : CMLS·Y ZhangH-B Shu
Apr 19, 2007·Nature Reviews. Genetics·Don X Nguyen, Joan Massagué
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yong Gu ChoWon Sang Park
Dec 20, 2007·Cancer Research·José AdélaïdeMax Chaffanet
May 3, 2008·Cancer Research·Marcel SmidJohn W M Martens
Aug 2, 2008·Neoplasia : an International Journal for Oncology Research·Wennuan LiuJianfeng Xu
May 2, 2009·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Aude LegofficJuan Lucio Iovanna
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Jul 8, 2009·Nucleic Acids Research·Wei SunCharles M Perou
Jul 14, 2009·Breast Cancer Research and Treatment·Antoinette HollestelleMieke Schutte
Jun 4, 2011·Breast Cancer Research and Treatment·Tian-Song XiaShui Wang
Sep 17, 2013·Veterinary and Comparative Oncology·P DeinnocentesR Curtis Bird
Oct 12, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca QuagliataLuigi M Terracciano
Nov 20, 2013·PloS One·Karin S KassahnJohn V Pearson
Feb 15, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J Lortet-TieulentF Bray
May 30, 2015·Breast Cancer Research and Treatment·Hongli DongPaul M Epstein
Mar 31, 2017·Genome Medicine·Vinodh SrinivasainagendraKeshav K Singh
Sep 11, 2017·Breast Cancer Research and Treatment·Jodi M SaunusSunil R Lakhani

❮ Previous
Next ❯

Citations

Oct 29, 2020·Journal of Biochemical and Molecular Toxicology·Mohammed A Mansour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.